Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Petter Höglund
Ibrutinib Induces Rapid Down-Regulation of Inflammatory Markers and Altered Transcription of Chronic Lymphocytic Leukaemia-Related Genes in Blood and Lymph Nodes
British Journal of Haematology
Hematology
NCRs and DNAM-1 Mediate NK Cell Recognition and Lysis of Human and Mouse Melanoma Cell Lines in Vitro and in Vivo
Journal of Clinical Investigation
Medicine
Related publications
Arresting the Inflammatory Drive of Chronic Lymphocytic Leukemia With Ibrutinib
Clinical Cancer Research
Cancer Research
Oncology
Comparison of Innate Immunity Changes Following Ibrutinib and Venetoclax Treatment of Relapsed Chronic Lymphocytic Leukaemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Lack of Adequate Pneumococcal Vaccination Response in Chronic Lymphocytic Leukaemia Patients Receiving Ibrutinib
British Journal of Haematology
Hematology
Unravelling the Suboptimal Response of TP53 -Mutated Chronic Lymphocytic Leukaemia to Ibrutinib
British Journal of Haematology
Hematology
Chronic Lymphocytic Leukaemia
Nature Reviews Disease Primers
Medicine
Ibrutinib Enhances the Efficacy of ROR1 Bispecific T Cell Engager Mediated Cytotoxicity in Chronic Lymphocytic Leukaemia
British Journal of Haematology
Hematology
Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia
Frontiers in Immunology
Allergy
Immunology
Beyond Ibrutinib Resistance in Chronic Lymphocytic Leukemia
Cancer therapy & Oncology International Journal
Cost-Effectiveness of Ibrutinib in Patients With Relapsed or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
